We are live on
!
Find out more
OC
Oppenheimer & Co Portfolio holdings
AUM
$9.37B
1-Year Est. Return
36.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.37%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$6.56B
AUM Growth
+$257M
(+4.1%)
Cap. Flow
-$95M
Cap. Flow
% of AUM
-1.45%
Top 10 Holdings %
Top 10 Hldgs %
20.09%
Holding
1,597
New
167
Increased
572
Reduced
670
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$14M |
| 2 |
Verizon
VZ
|
+$11.3M |
| 3 |
Vodafone
VOD
|
+$8.26M |
| 4 |
FT Vest Fund of Buffer ETFs
BUFR
|
+$4.71M |
| 5 |
GE Aerospace
GE
|
+$4.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$17.4M |
| 2 |
iShares Treasury Floating Rate Bond ETF
TFLO
|
+$16.1M |
| 3 |
Allegion
ALLE
|
+$7.38M |
| 4 |
CarMax
KMX
|
+$6.61M |
| 5 |
Alliance Resource Partners
ARLP
|
+$6.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.04% |
| 2 | Financials | 9.76% |
| 3 | Industrials | 8.72% |
| 4 | Healthcare | 8.38% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASG
1476
Liberty All-Star Growth Fund
ASG
$343M
| $63.4K | ﹤0.01% |
11,300
+247
| +2% | +$1.33K |
|
|
NAGE
1477
Niagen Bioscience
NAGE
$241M
| $61.7K | ﹤0.01% |
16,900
| – | – |
|
|
DHY
1478
Credit Suisse High Yield Credit Fund
DHY
$243M
| $57.3K | ﹤0.01% |
25,255
| – | – |
|
|
AMPS
1479
DELISTED
Altus Power
AMPS
| $47.7K | ﹤0.01% |
15,000
-5,000
| -25% | -$17.8K |
|
1480
Origin Agritech
SEED
$13M
| $42.6K | ﹤0.01% |
14,000
| – | – |
|
1481
Kopin
KOPN
$780M
| $42.3K | ﹤0.01% |
58,000
| – | – |
|
|
CD
1482
Chaince Digital Holdings
CD
$227M
| $39.1K | ﹤0.01% |
22,500
| – | – |
|
1483
Milestone Scientific
MLSS
$42M
| $38.7K | ﹤0.01% |
42,500
| – | – |
|
1484
Great Elm Group
GEG
$67.4M
| $38.5K | ﹤0.01% |
20,164
| – | – |
|
1485
Vivid Seats
SEAT
$82.6M
| $37K | ﹤0.01% |
+500
| New | +$45.6K |
|
1486
Stem
STEM
$50.9M
| $37K | ﹤0.01% |
5,308
-1,517
| -22% | -$23.9K |
|
1487
Ocugen
OCGN
$444M
| $35.9K | ﹤0.01% |
36,155
| – | – |
|
1488
Compugen
CGEN
$221M
| $35K | ﹤0.01% |
19,350
+8,350
| +76% | +$15.2K |
|
|
ALTM
1489
DELISTED
Arcadium Lithium plc
ALTM
| $34.8K | ﹤0.01% |
12,198
+1,992
| +20% | +$5.77K |
|
|
ADAP
1490
DELISTED
Adaptimmune Therapeutics
ADAP
| $34.5K | ﹤0.01% |
36,275
-3,023
| -8% | -$3.43K |
|
1491
Ceragon Networks
CRNT
$192M
| $32.9K | ﹤0.01% |
12,000
-20,000
| -63% | -$54.7K |
|
1492
Ondas Inc
ONDS
$5.31B
| $32.1K | ﹤0.01% |
41,692
| – | – |
|
1493
Allogene Therapeutics
ALLO
$725M
| $29.4K | ﹤0.01% |
10,500
| – | – |
|
1494
Cellectar Biosciences
CLRB
$20.8M
| $26.8K | ﹤0.01% |
+417
| New | +$27.5K |
|
1495
MDxHealth
MDXH
$23.3M
| $20.8K | ﹤0.01% |
+10,000
| New | +$27.2K |
|
1496
Accuray
ARAY
$34.9M
| $19.8K | ﹤0.01% |
+11,000
| New | +$20.9K |
|
1497
BARK
BARK
$96.7M
| $18.7K | ﹤0.01% |
575
| – | – |
|
1498
FuboTV Inc
FUBO
$276M
| $17.9K | ﹤0.01% |
1,049
-240
| -19% | -$4.33K |
|
|
ZPTA
1499
DELISTED
Zapata Computing Holdings Inc. Common Stock
ZPTA
| $13.6K | ﹤0.01% |
50,000
+10,000
| +25% | +$5K |
|
|
IAUX
1500
i-80 Gold Corp
IAUX
$1.47B
| $13.2K | ﹤0.01% |
+11,400
| New | +$11.9K |
|
Similar funds
AC
NPT
PVI
WPL
IAA
RCM
RCMNY
SIM
Oppenheimer & Co's Q3 2024 Portfolio in Review
As of Q3 2024, Oppenheimer & Co held 1,597 positions worth $6.56B, up 4.1% from $6.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Oppenheimer & Co's Q3 2024 filing shows 167 new, 572 increased, 670 reduced and 91 closed positions. Its largest new stake was Woodward: 22,875 shares worth $3.92M. The largest sale was Apple, an estimated $17.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Industrials.
- Oppenheimer & Co's largest Q3 2024 buy was Woodward: 22,875 shares worth $3.92M.
- Oppenheimer & Co added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q3 2024, an estimated $14M increase.
- Oppenheimer & Co's biggest Q3 2024 reduction was Apple, cutting an estimated $17.4M.
- Oppenheimer & Co fully exited Alliance Resource Partners in Q3 2024, selling an estimated $6.6M.
- Oppenheimer & Co's ten largest holdings make up 20% of its $6.56B portfolio in Q3 2024.
- Oppenheimer & Co opened 167 new positions and closed 91 in Q3 2024.
- Oppenheimer & Co's portfolio value rose 4.1% quarter-over-quarter to $6.56B.
Based on Oppenheimer & Co's 13F filing for Q3 2024, filed 5 Nov 2024.